Antiprogestagen RU486 prevents the LH-dependent decrease in the serum concentrations of inhibin in the rat

Area of Science:

• Reproductive Endocrinology
• Hormonal Regulation of Ovulation
• Ovarian Physiology

Background:

• Luteinizing hormone (LH) surge triggers ovarian progesterone production.
• Progesterone mediates LH effects on the ovary, including inhibin regulation.
• The role of progesterone in LH-dependent inhibin changes requires further investigation.

Purpose of the Study:

• To investigate the effect of the antiprogestagen RU486 on LH-dependent changes in serum and ovarian inhibin levels.
• To determine the role of progesterone in mediating the LH-induced decrease in inhibin.

Main Methods:

• Rats were treated with a gonadotropin-releasing hormone antagonist (GnRH-ant) to suppress endogenous LH.
• Groups received LH, RU486, or both, alongside a control group.
• Serum and ovarian inhibin, LH, FSH, progesterone, and 17 beta-estradiol were measured.

Main Results:

• LH administration decreased serum and ovarian inhibin and increased FSH.
• RU486 blocked the LH-induced decrease in serum inhibin but not ovarian inhibin.
• Progesterone appears to mediate the LH effect on serum inhibin levels.

Conclusions:

• Ovarian progesterone plays a role in the LH-dependent reduction of serum inhibin.
• Progesterone's function extends beyond mediating ovulation and luteinization to include inhibin regulation.
• These findings enhance understanding of hormonal feedback mechanisms in the ovarian cycle.